Ramelteon Tablet, Film Coated
Product Images NDC 0832-1250

2 FDA label images from Upsher-smith Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ramelteon (NDC 0832-1250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ramelteon 01)

Chemical Structure (Ramelteon 01)
Chemical structure of Ramelteon, showing its molecular formula with a distinctive fused ring system including a tetrahydrofuran ring and an indane moiety.*
FDA Label Image

Principal Display Panel (8 mg Tablet Bottle Label)

Principal Display Panel (8 mg Tablet Bottle Label)
Ramelteon Tablets 8 mg film-coated tablets packaging label by Upsher-Smith Laboratories, LLC. The label includes the proprietary name Ramelteon, strength 8 mg, quantity of 30 tablets, NDC 0832-1250-30, and storage instructions. It notes dispensing instructions and cautions such as protecting from moisture, proper sealing, and keeping out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.